Close

WST Financial Facts

Research and development: 9M
Cost of goods and services sold: 255.6M
See Full Income Statement

Investments in affiliated companies: 81.4M
Other noncurrent assets: 22.8M
See Full Balance Sheet

West Pharmaceutical Services, Inc. (WST) Earnings

  |   Expand Research on WST
Next EPS Date 4/25/24 EPS Growth Rate -34.3%
Average EPS % Beat Rate +11.9% Revenue Growth Rate -6.5%
Average % Move 1-Wk after EPS -5.5% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/16/23 Q422 $1.77$1.37 +$0.40$708.7M$657.17M = Details
7/26/18 Q218 $0.70$0.67 +$0.03$447.5M$424.49M = Details
4/27/17 Q117 $0.81$0.55 +$0.26$387.7M$380.42M = Details
4/23/20 Q120 $1.01$0.82 +$0.19$491.5M$466.79M = Details
10/26/17 Q317 $0.67$0.53 +$0.14$398.2M$385.9M = Details
7/25/19 Q219 $0.89$0.72 +$0.17$469.7M$460.4M = Details
2/13/20 Q419 $0.82$0.72 +$0.10$470.6M$451.53M = Details
4/25/19 Q119 $0.74$0.65 +$0.09$443.5M$430.67M = Details